Table 3.
OS |
||||
Site of tumor recurrence | No. of patients | 5-y rate (95% CI) | HR (95% CI) | P |
Overall <.001† | ||||
Local (reference) | 45 | 22.7 (13.2 to 39.2) | — | |
Intra-abdominal | 144 | 12.2 (7.7 to 19.3) | 1.72 (1.16 to 2.54) | .007‡ |
Distant | 429 | 7.8 (5.4 to 11.1) | 1.79 (1.25 to 2.55) | .001‡ |
Liver | 226 | 6.2 (3.7 to 10.6) | 1.91 (1.32 to 2.76) | <.001‡ |
Lung | 94 | 7.4 (2.8 to 19.4) | 1.33 (0.89 to 1.99) | .168‡ |
Liver and lung | 23 | 0.0 (0.0 to 0.0) | 3.55 (2.04 to 6.17) | <.001‡ |
Other distant | 86 | 12.1 (6.7 to 21.9) | 1.98 (1.31 to 2.99) | .001‡ |
Impact of the site of tumor recurrence on OS after colon cancer recurrence was determined using a landmark analysis. A Cox model, stratified by study, was used to estimate the effect for each site of tumor recurrence. CI = confidence interval; HR = hazard ratio.
P value was calculated using a two-sided score test.
P values were calculated using a two-sided Wald χ2 test.